Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$332,274
+$12,142 QoQ
Shares Held
2,630
+14.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#1,597
of 2,266 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Acorn Wealth Advisors, LLC holds $4,229,876 across 7 Drug Manufacturers - General names. GILD ranks #7 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,833 | $973,467 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,368 | $818,288 | |
| 3 | LLY |
ELI LILLY & Co
|
620 | $743,646 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
8,764 | $504,981 | |
| 5 | ABBV |
AbbVie Inc.
|
1,979 | $497,995 | |
| 6 | PFE |
Pfizer Inc
|
14,918 | $359,225 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,630 | $332,274 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $332,274 | 2,630 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $320,132 | 2,297 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $280,092 | 2,282 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $264,513 | 2,383 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $262,761 | 2,370 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $264,774 | 2,363 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $216,977 | 2,349 | Shares | Sole | 2025-02-04 | |
| 2021-12-31 | $204,324 | 2,814 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||